EMAIL DETAILS
SUBJECT:
Fwd: FYI
PRI: NORMAL
FROM:
P
perowan@gmail.com
DATE:
2014-10-23 20:48:26
MSG_ID:
<869BD3BA-E681-4898-9A6D-270A60A728DD@gmail.com>
RECIPIENTS:
TO:
B
Brian Rath
<brian.d.rath@gmail.com>
R
Hunter
<rhb@rspdc.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Sent from my iPhone Begin forwarded message: > From: Derrick Johns <derrick@difusiontech.com> > Date: October 23, 2014 at 4:15:21 PM EDT > To: Paul <perowan@gmail.com> > Subject: FYI > > RE: DiFusion > Bob Bargenquast > September 22, 2014 9:41 AM > Derrick, > > I agree. I was at an ACO/Payor conference week before last in Atlanta and met with folks from Humana, Aetna, etc. on this very issue. Their focus right now is on creating and tracking benchmarks for a variety of conditions and treatments. > > Spine is coming and the manufacturers that have something to offer by way of better clinical outcomes as well as providing economic advantages (quicker recovery time, less OR, etc.) over the current standard of care will be the ones best suited to survive this brave new world. > > Regards, > > Bob Bargenquast > > > On 09/21/14 2:49 PM, derrick johns wrote: > -------------------- > www.difusiontech.com > > Pretty good leverage under ACA...if you agree drop me a line. > > Derrick Johns > Founder & CE
METADATA:
THREAD:
INDEX:
AdhhndcGWvKe3uFMSvShk0ULAfJgyw==
REFERENCES:
REFS:
<544961dd.414c3c0a.7eb5.6335@mx.google.com>